Key facts
- This page summarizes Thomas E. Hogan's Form 3 filing for Cellebrite DI Ltd. (CLBT).
- 0 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 18 Mar 2026, 08:26.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
Includes 282,905 Ordinary Shares that are represented by restricted share units ("RSUs") that were granted on September 19, 2025 and vest on July 1, 2026. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.
Footnote F2
Includes 252,748 Ordinary Shares that are represented by RSUs that were granted on February 10, 2026 and vest as follows: 63,196 vest on the one year anniversary of the grant date and 15,796 vest every three months thereafter through February 10, 2030.
Footnote F3
Of these stock options, 625,000 are fully vested and exercisable and 62,500 vest on each of May 7, 2026 and every three months thereafter through August 7, 2027.
Footnote F4
These stock options are fully vested and exercisable.